Clearance Summary
SUCROSEP HUMAN GROWTH HORMONE (HGH) IRMA received FDA 510(k) clearance under submission number K860228, sponsored by Boots-Celltech Diagnostics, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1986-02-28.
- Submission: K860228
- Applicant / Sponsor: Boots-Celltech Diagnostics, Inc.
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class I
- Regulation citation: 21 CFR 862.1370
- Decision date: 1986-02-28
Classification & Regulation
This clearance is catalogued under FDA product code CFL and 21 CFR 862.1370, within the Clinical Chemistry review panel as a Class I device.